Prostate cancer screening, November 2018

David L. Keller

doi:10.3949/ccjm.85c.12001

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

REFERENCES

↵
1. Chaitoff A,
2. Killeen TC,
3. Nielsen C
. Men’s health 2018: BPH, prostate cancer, erectile dysfunction, supplements. Cleve Clin J Med 2018; 85(11):871–880. doi:10.3949/ccjm.85a.18011
OpenUrl Abstract/FREE Full Text
↵
1. US Preventive Services Task Force
. Prostate cancer: screening. May 2018. www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFi-nal/prostate-cancer-screening1?ds=1&s=PSA. Accessed November 6, 2018.
↵
1. Gupta SK
. Intention-to-treat concept: a review. Perspect Clin Res 2011; 2(3):109–112. doi:10.4103/2229-3485.83221
OpenUrl CrossRef PubMed
↵
1. Cancer.Net
. Prostate cancer: statistics. www.cancer.net/cancer-types/pros-tate-cancer/statistics. Accessed November 6, 2018.
↵
1. Lavallée LT,
2. Binette A,
3. Witiuk K,
4. et al
. Reducing the harm of prostate cancer screening: repeated prostate-specific antigen testing. Mayo Clin Proc 2016; 91(1):17–22. doi:10.1016/j.mayocp.2015.07.030
OpenUrl CrossRef

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.